Skip to main content

Parametrica Management Ltd

SEC CIK
0001535110
Latest filing
Aug 12, 2026

Holdings changes from Q1 2023 to Q2 2023

Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.

Choose two quarters to compare

New
9
Est. +$14.3M
Added
7
Est. +$3.83M
Reduced
9
Est. −$17.0M
Sold out
8
Est. −$10.3M

Portfolio value went from $55.4M to $51.9M (−$3.49M (−6.3%)); positions from 26 to 27 (+1).

All Q2 2023 holdingsAll Q1 2023 holdings

In the shares, value and % of portfolio columns, the top figure is Q2 2023 and the gray one below is Q1 2023. For stocks that split between the two quarters, Q1 2023 shares are converted at the split ratio before comparing.

Holdings of Parametrica Management Ltd in Q1 2023 and Q2 2023 compared
SecurityActionSharesShare changeValueEst. bought or sold% of portfolioWeight change (pp)
METAMeta Platforms, Inc.ReducedHistory30,40037,000−6,600−17.8%$8.72M$7.84M−$1.89M16.8%14.2%+2.65
VanEck Morningstar Wide Moat ETF92189F643New–68,3230+68,323$5.45M$0+$5.45M10.5%0.0%+10.50
GOOGLAlphabet Inc.ReducedHistory34,34368,407−34,064−49.8%$4.11M$7.10M−$4.08M7.9%12.8%−4.89
LLYEli Lilly & CoReducedHistory7,7757,827−52−0.7%$3.65M$2.69M−$24.4K7.0%4.9%+2.17
MSFTMicrosoft CorpReducedHistory9,58027,346−17,766−65.0%$3.26M$7.88M−$6.05M6.3%14.2%−7.94
REGNRegeneron Pharmaceuticals, Inc.AddedHistory3,9843,123+861+27.6%$2.86M$2.57M+$618.7K5.5%4.6%+0.88
MELIMercadolibre IncAddedHistory2,0971,165+932+80.0%$2.48M$1.54M+$1.10M4.8%2.8%+2.01
AMATApplied Materials IncAddedHistory14,00010,200+3,800+37.3%$2.02M$1.25M+$549.3K3.9%2.3%+1.64
Vanguard Health Care ETF92204A504New–8,1000+8,100$1.98M$0+$1.98M3.8%0.0%+3.82
ALNYAlnylam Pharmaceuticals, Inc.AddedHistory10,2465,953+4,293+72.1%$1.95M$1.19M+$815.4K3.7%2.2%+1.60
ADBEAdobe Inc.ReducedHistory3,5203,968−448−11.3%$1.72M$1.53M−$219.1K3.3%2.8%+0.56
PDDPDD Holdings Inc.ReducedHistory24,70043,375−18,675−43.1%$1.71M$3.29M−$1.29M3.3%5.9%−2.65
SPGIS&P Global Inc.NewHistory3,5130+3,513$1.41M$0+$1.41M2.7%0.0%+2.71
YMMFull Truck Alliance Co. Ltd.AddedHistory202,698141,513+61,185+43.2%$1.26M$1.08M+$380.6K2.4%1.9%+0.48
BIDUBaidu, Inc.ReducedHistory9,10022,432−13,332−59.4%$1.25M$3.39M−$1.83M2.4%6.1%−3.71
LILi Auto Inc.NewHistory35,1000+35,100$1.23M$0+$1.23M2.4%0.0%+2.37
BABAAlibaba Group Holding LtdNewHistory14,5000+14,500$1.21M$0+$1.21M2.3%0.0%+2.33
TSLATesla, Inc.NewHistory4,5440+4,544$1.19M$0+$1.19M2.3%0.0%+2.29
TXG10x Genomics, Inc.AddedHistory14,80014,361+439+3.1%$826.4K$801.2K+$24.5K1.6%1.4%+0.15
NVONovo Nordisk A SReducedHistory5,10015,000−9,900−66.0%$825.3K$2.39M−$1.60M1.6%4.3%−2.72
State Street SPDR S&P Biotech ETF78464A870New–8,2000+8,200$682.6K$0+$682.6K1.3%0.0%+1.31
IOVAIovance Biotherapeutics, Inc.AddedHistory96,50048,700+47,800+98.2%$679.4K$297.6K+$336.5K1.3%0.5%+0.77
DISWalt Disney CoNewHistory7,4450+7,445$664.7K$0+$664.7K1.3%0.0%+1.28
BILLBILL Holdings, Inc.NewHistory4,3000+4,300$502.5K$0+$502.5K1.0%0.0%+0.97
ARBEArbe Robotics Ltd.ReducedHistory33,51234,287−775−2.3%$95.8K$109.4K−$2.22K0.2%0.2%−0.01
IPSCCentury Therapeutics, Inc.UnchangedHistory27,84027,84000.0%$88.0K$96.6K$00.2%0.2%0.00
FATEFate Therapeutics IncUnchangedHistory18,47218,47200.0%$87.9K$105.3K$00.2%0.2%−0.02
BEKEKE Holdings Inc.Sold outHistory0203,892−203,892−100.0%$0$3.84M−$3.84M0.0%6.9%−6.93
NOWServiceNow, Inc.Sold outHistory03,140−3,140−100.0%$0$1.46M−$1.46M0.0%2.6%−2.63
NVDANVIDIA CorpSold outHistory05,063−5,063−100.0%$0$1.41M−$1.41M0.0%2.5%−2.54
LNTHLantheus Holdings, Inc.Sold outHistory015,300−15,300−100.0%$0$1.26M−$1.26M0.0%2.3%−2.28
AMDAdvanced Micro Devices IncSold outHistory012,200−12,200−100.0%$0$1.20M−$1.20M0.0%2.2%−2.16
MTCHMatch Group, Inc.Sold outHistory027,251−27,251−100.0%$0$1.05M−$1.05M0.0%1.9%−1.89
SABRSabre CorpSold outHistory012,000−12,000−100.0%$0$51.5K−$51.5K0.0%0.1%−0.09
CDAKCodiak BioSciences, Inc.Sold outHistory065,098−65,098−100.0%$0$11.0K−$11.0K0.0%<0.1%−0.02

Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.